Derek Winstanly
Chief Customer & Governance Officer @ Novaquest Capital Management
Derek Winstanly is a startup investor at Novaquest Capital Management. Dr. Derek Winstanly joined Quintiles in 1999 as President of Quintiles Japan becoming chairman of Japan and Regional Director for the Asia-Pacific Region in 2002. In September 2010, Quintiles named Dr. Winstanly Chief Customer and Governance Officer for Quintiles, based near Research Triangle Park, North Carolina.In this global role, Dr.Winstanly works with senior executives of pharmaceutical and biotechnology companies to provide long-term strategic solutions. In addition, Dr. Winstanly is responsible for the office of the Chief Medical and Scientific Officer, Quality Assurance and Business Ethic functions.Prior to joining Quintiles, Dr. Winstanly worked for Glaxo Wellcome, plc, now GlaxoSmithKline, for 15 years, most recently serving as President of Nippon Wellcome, now GlaxoSmithKline K.K., in Japan.Dr. Winstanly graduated as a Medical Doctor MBChB from the University of Pretoria, South Africa in 1972 and is registered as Medical Practitioner in both the U.K. and South Africa.
Last updated:
For AI agents: llms.txt
About Novaquest Capital Management
NovaQuest Capital Management, LLC (NovaQuest) manages product and company investments in the global healthcare industry. Its primary focus is structured finance investments in late-stage clinical and commercialized biopharmaceutical products. NovaQuest invests side-by-side with global companies in their most strategic product programs, ensuringalignment with the biopharmaceutical companies. These customized, product transactions are an alternative to standard biopharmaceutical industry deal-making and help companies maximize the value of their product portfolios. In addition, NovaQuest invests in select private equity and other company securities, with a consistent focus on late-stage clinical and commercialized products.The NovaQuest team has worked together for over 12 years, investing over $1 billion into the global healthcare industry. The team began pursuing its strategy in 2000 as an investment group within Quintiles Transnational Holdings Inc. (Quintiles). Today, NovaQuest Capital Management is an independent firm managing global investment capital. It is backed by investors whose relationships with NovaQuest date back to the group’s inception. NovaQuest is meeting the evolving needs of global healthcare companies and its investors with a consistent strategy, developed over multiple years and transactions, that draws on a customized mix of investment and return elements and securities.
Novaquest Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brian Axe
Partner
|
|||
Dennis Gillings
Executive Chairman
|
|||
|
Derek Winstanly
Chief Customer & Governance Officer
|
|||
James Erlinger
General Counsel
|
|||
Paula Brown Stafford
president
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
